 | Up a level |
Journal Article
Ahmadzadehfar, H., Albers, P., Bockisch, A., Boegemann, M., Boehme, C., Burchert, W., Dietlein, M., Drzezga, A., Fabry, U., Feldmann, G., Heidenreich, A., Heinzel, A., Herrmann, K., Heyll, A., Hoehling, C., Kreuzer, C., Laufer, D., Mengel, R., Mottaghy, F. M., Mueller, H-W., Mueller, S. C., Ost, E., Rahbar, K., Reifenhaeuser, W., Schaefers, M., Schlenkhoff, C., Schmidt, M., Schmidt-Wolf, I., Wildenhain, C., Zimmer, B. and Essler, M. (2018). Lutetium-177-PSMA radioligand therapy. Consensus within the framework of GKV-funded care between the university hospitals in Aachen, Bonn, Dusseldorf, Essen, and Cologne and the MDK Nordrhein. Urologe, 57 (6). S. 709 - 714. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0563
Altomare, D., Festari, C., Rivolta, J., Gandolfo, F., Orini, S., Drzezga, A., Nobili, F. and Boccardi, M. (2017). Diagnostic utility of FDG-PET in identifying AD dementia with atypical presentation or atypical course. Eur. J. Neurol., 24. S. 610 - 611. HOBOKEN: WILEY. ISSN 1468-1331
Ashton, N. J., Leuzy, A., Karikari, T. K., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Nordberg, A., Ossenkoppele, R., Zetterberg, H., Blennow, K., Frisoni, G. B., Garibotto, V. and Hansson, O. (2021). The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. Eur. J. Nucl. Med. Mol. Imaging, 48 (7). S. 2140 - 2157. NEW YORK: SPRINGER. ISSN 1619-7089
Bacher, R., Dietlein, M., Kobe, C., Hohberg, M., Wild, M., Drzezga, A. and Schmidt, M. (2018). Retrospective comparison of thyroid and whole-body residence time of radioiodine in patients with differentiated thyroid carcinoma at initial ablative radioiodine therapy and follow-up whole-body scintigraphy after a short period of hypothyroidism or under rhTSH stimulation. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S606 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Bailey, D. L., Pichler, B. J., Gueckel, B., Barthel, H., Beer, A. J., Bremerich, J., Czernin, J., Drzezga, A., Franzius, C., Goh, V., Hartenbach, M., Iida, H., Kjaer, A., la Fougere, C., Ladefoged, C. N., Law, I., Nikolaou, K., Quick, H. H., Sabri, O., Schaefer, J., Schaefers, M., Wehrl, H. F. and Beyer, T. (2015). Combined PET/MRI: Multi-modality Multi-parametric Imaging Is Here. Mol. Imaging. Biol., 17 (5). S. 595 - 609. NEW YORK: SPRINGER. ISSN 1860-2002
Bohn, K. P., Foerster, S., Bischof, G., Hammes, J., van Eimeren, T. and Drzezga, A. (2018). Detection of triple-pathology disease windows by means of multimodal imaging in patients with Alzheimer's disease and mild cognitive impairment with probable Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S269 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Brendel, M., Palleis, C., Prix, C., Finze, A., Boetzel, K., Danek, A., Hoellerhage, M., Beyer, L., Sauerbeck, J., Rauchmann, B., Stephens, A., Drzezga, A., van Eimeren, T., Barthel, H., Patt, M., Sabri, O., Villemagne, V., Bartenstein, P., Perneczky, R., Haass, C., Levin, J. and Hoeglinger, G. (2020). F-18-PI-2620 Tau-PET in Corticobasal Syndrome. Eur. J. Nucl. Med. Mol. Imaging, 47 (SUPPL 1). S. S93 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Buschiazzo, A., Frisoni, G., Galluzzi, S., Perneczky, R., Drzezga, A., van Berckel, B., Ossenkoppele, R., Guedj, E., Didic, M., Mecocci, P., Dottorini, M., Bauckneht, M., Sambuceti, G., Nobili, F. and Morbelli, S. (2016). Interaction between education and clinical expression of Alzheimer's disease across European countries: an 18F-FDG PET study of the European Alzheimer's Disease Consortium (EADC). Eur. J. Nucl. Med. Mol. Imaging, 43. S. S116 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Caroli, A., Prestia, A., Galluzzi, S., Ferrari, C., van der Flier, W. M., Ossenkoppele, R., Van Berckel, B., Barkhof, F., Teunissen, C. E., Wall, A., Carter, S. F., Scholl, M., Choo, I. H., Grimmer, T., Nordberg, A., Scheltens, P., Drzezga, A. and Frisoni, G. B. (2014). Mild cognitive impairment with suspected non AD pathology (SNAP): prediction of progression to dementia. J. Neurol., 261. S. S14 - 1. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1432-1459
Caroli, A., Prestia, A., Galluzzi, S., Ferrari, C., van der Flier, W. M., Ossenkoppele, R., Van Berckel, B., Barkhof, F., Teunissen, C. E., Wall, A., Carter, S. F., Scholl, M., Choo, I. H., Grimmer, T., Nordberg, A., Scheltens, P., Drzezga, A. and Frisoni, G. B. (2014). Mild cognitive impairment with suspected non AD pathology (SNAP): prediction of progression to dementia. Eur. J. Neurol., 21. S. 19 - 20. HOBOKEN: WILEY-BLACKWELL. ISSN 1468-1331
Dietlein, M. and Drzezga, A. (2018). Ablative Radioiodine Therapy for treating Patients with Thyroid Cancer Standardized versus personalized De-escalation of I-131 Activity. Nuklearmedizin, 57 (4). S. 118 - 124. STUTTGART: GEORG THIEME VERLAG KG. ISSN 0029-5566
Dietlein, M., Kuhnert, G., Semrau, R., Nast-Kolb, B., Baues, C., Fuchs, M., Drzezga, A. and Kobe, C. (2014). Current importance of positron emission tomography in Hodgkin's lymphoma. Onkologe, 20 (5). S. 429 - 439. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1433-0415
Doering, E., Hoenig, M. C., Bischof, G. N., Bohn, K. P., Ellingsen, L. M., van Eimeren, T. and Drzezga, A. (2022). Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment. Eur. J. Nucl. Med. Mol. Imaging, 49 (13). S. 4478 - 4490. NEW YORK: SPRINGER. ISSN 1619-7089
Drzezga, A. (2013). Multimodal imaging of neuronal function and dysfunction. Eur. Neuropsychopharmacol., 23. S. S145 - 1. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 1873-7862
Endepols, H., Morgenroth, A., Zlatopolskiy, B. D., Krapf, P., Vasquez, S. Munoz, Drzezga, A., Richarz, R., Neumaier, B. and Mottaghy, F. (2018). Peripheral ganglia of the rat: A tumor-free model to evaluate PSMA-specific PET-tracers. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S238 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hammes, J., Bischof, G., Anderl-Straub, S., Barthel, H., Beer, A. J., Danek, A., Eickhoff, S., Fassbender, K., Fliessbach, K., Landwehrmeyer, B., Lauer, M., Ludolph, A. C., Prudlo, J., Schroeter, M. L., Sabri, O., Schmidt-Diehl, J., Schneider, A., Semler, E., Wiltfang, J., Drzezga, A., Otto, M. and van Eimeren, T. (2018). Characterization of disease-specific covariance patterns of neurodegeneration in FTLD-variants. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S229 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hammes, J., Bischof, G., Fliessbach, K., Giehl, K., Jessen, F., Neumaier, B., Kukolja, J., Onur, I., Drzezga, A. and van Eimeren, T. (2016). Different binding behavior of the Tau-PET tracer [F-18]-AV-1451 in AD and Tau-positive FTLD. J. Neurochem., 138. S. 377 - 378. HOBOKEN: WILEY-BLACKWELL. ISSN 1471-4159
Hammes, J., Hohberg, M., Taeger, P., Wild, M., Zlatopolskiy, B., Krapf, P., Neumaier, B., Schomaecker, K., Kobe, C., Schmidt, M., Dietlein, M. and Drzezga, A. (2018). Uptake In Non-affected Bone Tissue Does Not Differ Between [18f]-DCFPyL And [68Ga]-HBED-CC PSMA PET/CT. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S535 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hammes, J., Leuwer, I., Bischof, G. N., Drzezga, A. and van Eimeren, T. (2017). Flortaucipir perfusion PET is a suitable replacement for FDG PET in patients with neurodegenerative diseases. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S250 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hoenig, M., Bischof, G., Kukolja, J., Onur, O., Jessen, F., Fliessbach, K., Neumaier, B., Kalbe, E., Drzezga, A. and van Eimeren, T. (2018). Effects of tau-pathology on glucose metabolism mitigated by level of education. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S102 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Hohberg, M., Dietlein, M., Kobe, C., Dietlein, F., Zlatopolskiy, B., Krapf, P., Wild, M., Taeger, P., Neumaier, B. and Drzezga, A. (2018). Biodistribution and radiation dosimetry of the novel F-18-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S149 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Hohberg, M., Eschner, W., Schmidt, M., Dietlein, M., Kobe, C., Fischer, T., Drzezga, A. and Wild, M. (2016). Radiation dosimetry of organs and tissues at risk from Lu-177-DKFZ-PSMA-617 for prostate cancer therapy. Eur. J. Nucl. Med. Mol. Imaging, 43. S. S414 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Hohberg, M., Kobe, C., Taeger, P., Hammes, J., Schmidt, M., Dietlein, F., Wild, M., Heidenreich, A., Drzezga, A. and Dietlein, M. (2019). Combined Early and Late [Ga-68]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels. Mol. Imaging. Biol., 21 (3). S. 558 - 567. NEW YORK: SPRINGER. ISSN 1860-2002
Kobe, C., Goergen, H., Fuchs, M., Eich, H. T., Baues, C., Diehl, V., Kuhnert, G., Drzezga, A., Dietlein, M., Engert, A. and Borchmann, P. (2017). Treatment Reduction in Patients with Advanced-Stage Hodgkin Lymphoma and Negative Interim FDG-PET: Final Results of the International, Randomized, Phase 3 HD18 Trial by the German Hodgkin Study Group. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S312 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Kobe, C., Kuhnert, G., Haverkamp, H., Fuchs, M., Kahraman, D., Eich, H. -T., Kriz, J., Baues, C., Nast-Kolb, B., Broeckelmann, P. J., Borchmann, P., Drzezga, A., Engert, A. and Dietlein, M. (2015). Concordance in the interpretation of PET after chemotherapy in advanced stage Hodgkin lymphoma. Nuklearmedizin, 54 (6). S. 241 - 247. STUTTGART: GEORG THIEME VERLAG KG. ISSN 2567-6407
Kuhnert, G., Boellaard, R., Kahramann, D., Scheffler, M., Wolf, J., Dietlein, M., Drzezga, A. and Kobe, C. (2015). PET/CT Reconstruction and Its Impact on Quantitative Image Analysis. Eur. J. Nucl. Med. Mol. Imaging, 42. S. S712 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Leuzy, A., Ashton, N. J., Mattsson-Carlgren, N., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Nordberg, A., Ossenkoppele, R., Zetterberg, H., Blennow, K., Frisoni, G. B., Garibotto, V. and Hansson, O. (2021). 2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework. Eur. J. Nucl. Med. Mol. Imaging, 48 (7). S. 2121 - 2140. NEW YORK: SPRINGER. ISSN 1619-7089
Linde, P., Baues, C., Marnitz, S., Rosenbrock, J., Celik, E., Quaas, A., Fischer, T., Schomaecker, K., Drzezga, A., Wester, H. -J and Kobe, C. (2020). (68) Ga-Pentixafor-PET/CT-based Radiation Planning in Patients with Esophageal Cancer. Strahlenther. Onkol., 196 (SUPPL 1). S. S149 - 2. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X
Messerschmidt, K., Barthel, H., Brendel, M., Van Eimeren, T., Marek, K., Villemagne, V., Rumpf, J., Saur, D., Schroeter, M., Rullmann, M., Hoffmann, K., Scherlach, C., Rauchmann, B., Schildan, A., Patt, M., Beyer, L., Song, M., Palleis, C., Gehmeyr, M., Fietzek, U., Respondek, G., Sauerbeck, J., Nitschmann, A., Zach, C., Hammes, J., Barbe, M., Onur, O., Jessen, F., Neumaier, B., Barret, O., Madonia, J., Russell, D., Stephens, A., Roeber, S., Herms, J., Boetzel, K., Bartenstein, P., Levin, J., Drzezga, A., Seibyl, J., Hoeglinger, G., Classen, J. and Sabri, O. (2020). [18F]PI-2620 Tau PET to Improve Imaging-Based Diagnosis of PSP. Eur. J. Nucl. Med. Mol. Imaging, 47 (SUPPL 1). S. S94 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Morbelli, S., Pagani, M., De Carli, F., Oberg, J., Buschiazzo, A., Frisoni, G., Drzezga, A., van Berckel, B. N., Guedj, E., Picco, A., Arnaldi, D., Ferrara, M., Chincarini, A., Nobili, F. and Brugnolo, A. (2015). Head-to-head comparisons of semi-quantification tools for brain FDG-PET in diagnosis of prodromal Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging, 42. S. S237 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Nobili, F., Arbizu, J., Bouwman, F., Drzezga, A., Agosta, F., Nestor, P., Walker, Z. and Boccardi, M. (2018). European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain F-18-fluorodeoxyglucose positron emission tomography in neurodegenerative cognitive impairment and dementia: Delphi consensus. Eur. J. Neurol., 25 (10). S. 1201 - 1218. HOBOKEN: WILEY. ISSN 1468-1331
Picco, A., Bossert, I., Buschiazzo, A., Frisoni, G. B., Caroli, A., van Berckel, B. N. M., Ossenkoppele, R., Drzezga, A., Perneczky, R., Didic, M., Guedj, E., Brugnolo, A., Bottoni, G., Arnaldi, D., Pagani, M., Sambuceti, G., Morbelli, S. and Nobili, F. (2014). Performance of [18F]FDG-PET in 142 MCI pazients with at least 2 years clinical follow up: a multicentric study of the European Alzheimer Disease Consortium (EADC). J. Alzheimers Dis., 41. S. S39 - 2. AMSTERDAM: IOS PRESS. ISSN 1875-8908
Reifegerst, M., Hohberg, M., Hammes, J., Drzezga, A. and Wild, M. (2018). LuISA - Lu-177-PSMA intelligent szintigraphy application. Eur. J. Nucl. Med. Mol. Imaging, 45. S. S225 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Roesel, K., Schneider, C., Kobe, C., Dietlein, M., Drzezga, A. and Schmidt, M. C. (2015). Tc-99m MIBI-scintigraphy for malignancy risk assessment of hypofunctionning thyroid nodules. Eur. J. Nucl. Med. Mol. Imaging, 42. S. S66 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Scherr, M., Utz, L., Grimmer, T., Drzezga, A., Sorg, C. and Riedl, V. (2017). Effective connectivity in the default mode network is distinctively disrupted in Alzheimer's disease. J. Cereb. Blood Flow Metab., 37. S. 229 - 231. THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 1559-7016
Schmidt, M. C., Hero, B., Decarolis, B., Eggert, A., Berthold, F., Drzezga, A. and Simon, T. (2017). I-131-mIBG therapy in high-risk neuroblastoma patients at end of induction chemotherapy. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S772 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Schmidt, M. C., Hero, B., Decarolis, B., Eggert, A., Berthold, F., Drzezga, A. and Simon, T. (2016). I-131-meta-iodobenzylguanidine therapy improves survival in high-risk neuroblastoma patients with I-123-mIBG positive residual metastatic disease. Eur. J. Nucl. Med. Mol. Imaging, 43. S. S31 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Schmidt, M. C., Pfister, O., Kobe, C., Dietlein, M., Dietlein, M., Heidenreich, A. and Drzezga, A. (2017). Tc-99m-PSMA-guided intraoperative lymph node localization in recurrent prostate cancer. Eur. J. Nucl. Med. Mol. Imaging, 44. S. S750 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Schomaecker, K., Fischer, T., Zimmermanns, B., Bregulla, J., Sudbrock, F., Prante, O. and Drzezga, A. (2017). Retention efficacy and release of radioiodine in fume hoods. J. Environ. Radioact., 166. S. 175 - 181. OXFORD: ELSEVIER SCI LTD. ISSN 1879-1700
Sudbrock, F., Fischer, Th., Zimmermanns, B., Drzezga, A. and Schomaecker, K. (2017). Exhalation of I-131 after radioiodine therapy: Dosimetric considerations based on measurements in exhaled air. J. Environ. Radioact., 166. S. 162 - 166. OXFORD: ELSEVIER SCI LTD. ISSN 1879-1700
Sudbrock, F., Herrmann, A., Fischer, T., Zimmermanns, B., Baus, W., Drzezga, A. and Schomaecker, K. (2017). Influence of iodine supply on the radiation-induced DNA-fragmentation. J. Environ. Radioact., 166. S. 157 - 162. OXFORD: ELSEVIER SCI LTD. ISSN 1879-1700
Sudbrock, F., Schomaecker, K. and Drzezga, A. (2017). The effectiveness of wastewater treatment in nuclear medicine: Performance data and radioecological considerations. J. Environ. Radioact., 166. S. 202 - 208. OXFORD: ELSEVIER SCI LTD. ISSN 1879-1700
Taeger, P. A., Hammes, J., Hohberg, M., Wild, M., Schomaecker, K., Kobe, C., Pfister, D., Heidenreich, A., Dietlein, M., Schmidt, M. and Drzezga, A. (2018). Discrete evaluation of multi-cycle Lu-177-PSMA-617-therapy effects on bone versus lymph node metastases in patients with metastasized castrationresistant prostate cancer (mCRPC). Eur. J. Nucl. Med. Mol. Imaging, 45. S. S126 - 1. NEW YORK: SPRINGER. ISSN 1619-7089
Trombella, S., Antelmi, L., Bosco, P., Redolfi, A., Tabouret-Viaud, C., Rager, O., Gold, G., Giannakopoulos, P., Ratib, O., Morbelli, S., Nobili, F. M., Perneczky, R., Didic, M., Guedj, E., Drzezga, A., Ossenkoppele, R., van Berckel, B., Frisoni, G. B. and Garibotto, V. (2016). Brain FDG-PET analysis in patients suspected with Alzheimer's disease: comparison between computer-aided reading using SPM and BRASS. Swiss Med. Wkly., 146. S. 84S - 85. MUTTENZ: E M H SWISS MEDICAL PUBLISHERS LTD. ISSN 1424-3997
Tscheuschler, M., Gebest, M., Jessen, F. and Drzezga, A. (2018). The importance of molecular imaging (PET) in the diagnostics of dementia. Nervenarzt, 89 (7). S. 843 - 855. NEW YORK: SPRINGER. ISSN 1433-0407
Uhrhan, K., Drzezga, A. and Sudbrock, F. (2014). THE PATIENTAS A RADIOACTIVE SOURCE: AN INTERCOMPARISON OF SURVEY METERS FOR MEASUREMENTS IN NUCLEAR MEDICINE. Radiat. Prot. Dosim., 162 (1-2). S. 101 - 105. OXFORD: OXFORD UNIV PRESS. ISSN 1742-3406
Voltin, C., Stockter, S., Baues, C., Fuchs, M., Dietlein, M., Mettler, J., Engert, A., Borchmann, P., Drzezga, A. and Kobe, C. (2017). Staging Patients with Hodgkin Lymphoma - Is Bone Marrow Biopsy Still Necessary in the Era of F-18-FDG PET? Eur. J. Nucl. Med. Mol. Imaging, 44. S. S244 - 2. NEW YORK: SPRINGER. ISSN 1619-7089
Voltin, C. -A., Goergen, H., Baues, C., Fuchs, M., Mettler, J., Kreissl, S., Oertl, J., Klaeser, B., Moccia, A., Drzezga, A., Engert, A., Borchmann, P., Dietlein, M. and Kobe, C. (2018). Value of bone marrow biopsy in Hodgkin lymphoma patients staged by FDG PET: results from the German Hodgkin Study Group trials HD16, HD17, and HD18. Ann. Oncol., 29 (9). S. 1926 - 1932. OXFORD: OXFORD UNIV PRESS. ISSN 1569-8041
Werner, P., Barthel, H., Drzezga, A. and Sabri, O. (2015). Current status and future role of brain PET/MRI in clinical and research settings. Eur. J. Nucl. Med. Mol. Imaging, 42 (3). S. 512 - 527. NEW YORK: SPRINGER. ISSN 1619-7089
Werner, P., Barthel, H., Drzezga, A. and Sabri, O. (2015). Current status and future role of brain PET/MRI in clinical and research settings. Eur. J. Nucl. Med. Mol. Imaging, 42 (3). S. 512 - 527. NEW YORK: SPRINGER. ISSN 1619-7089
Wolters, E. E., Dodich, A., Boccardi, M., Corre, J., Drzezga, A., Hansson, O., Nordberg, A., Frisoni, G. B., Garibotto, V and Ossenkoppele, R. (2021). Clinical validity of increased cortical uptake of [F-18]flortaucipir on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase biomarker development framework. Eur. J. Nucl. Med. Mol. Imaging, 48 (7). S. 2097 - 2110. NEW YORK: SPRINGER. ISSN 1619-7089
Yousefi, B. Hooshyar, Manook, A., von Reutern, B., Grimmer, T., Drzezga, A., Foerster, S., Schwaiger, M. and Wester, H. J. (2014). Preclinical Exploration of a Novel Class of PET Tracers for Amyloid-beta and CAA Depositions. Eur. J. Nucl. Med. Mol. Imaging, 41. S. S198 - 1. NEW YORK: SPRINGER. ISSN 1619-7089